glp 1 receptors in brain GLP-1 receptor agonists show promise treating substance use disorders Repurposing glucagon-like peptide-1 receptor agonists

This groundbreaking medication has shown promising results in promoting glycemic control and improving the quality of life for people with diabetes

Use shakes as supplements, not replacements

Plasma levels peak within 30 minutes of subcutaneous injection and return to baseline within 23 hours

In consideration of the reduced compliance of peptide GLP-1 receptor agonists due to subcutaneous injection, oral micromolecular GLP-1 receptor agonists such as orforglipron have already in clinical trials, which can reduce body weight and improve cardiac metabolism in adults with obesity (Wharton et al 2023) (Fig

In 1989, Takahashi et al

CYP450 are the most common metabolizing enzymes, found in the liver, duodenum, and proximal jejunum